Literature DB >> 25553

Cardiovascular actions of bromocriptine.

B J Clark, G Scholtysik, E Flückiger.   

Abstract

Bromocriptine lowers blood pressure in animals and in man. Results obtained in experiments performed in the dog and cat suggest three possible mechanisms of action: a) relaxation of vascular smooth muscle, principally in splanchnic and renal vessels, (b) inhibition of transmitter release from noradrenergic nerve endings, (c) central inhibition of sympathetic nerve activity. The effect of bromocriptine at each putative site of action can be explained in terms of dopamine receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25553

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  11 in total

1.  Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.

Authors:  C de Mey; D Enterling; I Meineke; S Yeulet
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

Review 2.  Bromocriptine in the treatment of parkinsonism.

Authors:  J D Parkes
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

3.  Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.

Authors:  S F Stewart; T A Pugsley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

4.  DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.

Authors:  W Birkmayer; G Birkmayer; H Lechner; P Riederer
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

5.  Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.

Authors:  E Flückiger; U Briner; B Clark; A Closse; A Enz; P Gull; A Hofmann; R Markstein; L Tolcsvai; H R Wagner
Journal:  Experientia       Date:  1988-05-15

6.  Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

7.  Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.

Authors:  W J Lang; O L Woodman
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

8.  Bromocriptine in the treatment of hypertension.

Authors:  R J Walden; J Hernandez; P Bhattacharjee; B Graham; B N Prichard
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.

Authors:  R M Carey; M O Thorner; E M Ortt
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

Review 10.  Adverse effects of antiparkinsonian drugs.

Authors:  J D Parkes
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.